NCT07033091 Prevalence of Human Papillomavirus (HPV) in a Healthy Population: A Feasibility Study of Oropharyngeal Cancer Screening
| NCT ID | NCT07033091 |
| Status | Recruiting |
| Phase | — |
| Sponsor | The Institute of Molecular and Translational Medicine, Czech Republic |
| Condition | Oropharynx Cancer |
| Study Type | INTERVENTIONAL |
| Enrollment | 20,000 participants |
| Start Date | 2025-06-01 |
| Primary Completion | 2030-12-31 |
Eligibility & Interventions
Eligibility Fast-Check
Enter your details for a quick preliminary check. This does not replace medical advice.
What to Expect as a Participant
You will actively receive the study intervention — which may be a drug, biologic, device, or procedure.
This trial targets 20,000 participants in total. It began in 2025-06-01 with a primary completion date of 2030-12-31.
⚠ This information is for research awareness only. Always consult your physician before joining any clinical trial. Participation is voluntary and you may withdraw at any time.
Brief Summary
This study defines the prevalence of oral infection with high-risk human papillomaviruses (hrHPV) in individuals over 40 years of age in the Czech Republic. It also establishes an effective methodology for oropharyngeal carcinoma screening and optimization of screening and testing procedures.
Eligibility Criteria
Inclusion Criteria: * Participants aged 40 years or older at the time of enrollment. * Individuals who are capable of rinsing the oral cavity by gargling independently. * Signed informed consent for study participation, molecular-genetic testing, and personal data processing. Exclusion Criteria: \- Previously diagnosed head and neck cancer.
Contact & Investigator
Marian Hajduch, Ph.D.
STUDY DIRECTOR
Faculty of Medicine and Dentistry, Palacky University, Olomouc
Frequently Asked Questions
Who can join the NCT07033091 clinical trial?
This trial is open to participants of all sexes, aged 40 Years or older, studying Oropharynx Cancer. Full inclusion and exclusion criteria are listed in the Eligibility Criteria section. Always confirm your eligibility with the research team before applying.
Is NCT07033091 currently recruiting?
Yes, NCT07033091 is actively recruiting participants. Contact the research team at vladimira.koudelakova@upol.cz for enrollment information.
Where is the NCT07033091 trial being conducted?
This trial is being conducted at Brno, Czechia, Brno, Czechia, Jihlava, Czechia, Olomouc, Czechia and 1 additional location.
Who is sponsoring the NCT07033091 clinical trial?
NCT07033091 is sponsored by The Institute of Molecular and Translational Medicine, Czech Republic. The principal investigator is Marian Hajduch, Ph.D. at Faculty of Medicine and Dentistry, Palacky University, Olomouc. The trial plans to enroll 20,000 participants.
Related Trials
Related Intelligence Guides
In-depth guides covering this condition's trials, eligibility, and what to expect.